310 related articles for article (PubMed ID: 22372499)
1. Mucin-based targeted pancreatic cancer therapy.
Torres MP; Chakraborty S; Souchek J; Batra SK
Curr Pharm Des; 2012; 18(17):2472-81. PubMed ID: 22372499
[TBL] [Abstract][Full Text] [Related]
2. Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy.
Rachagani S; Torres MP; Kumar S; Haridas D; Baine M; Macha MA; Kaur S; Ponnusamy MP; Dey P; Seshacharyulu P; Johansson SL; Jain M; Wagner KU; Batra SK
J Hematol Oncol; 2012 Oct; 5():68. PubMed ID: 23102107
[TBL] [Abstract][Full Text] [Related]
3. Mucins in pancreatic cancer: A well-established but promising family for diagnosis, prognosis and therapy.
Wang S; You L; Dai M; Zhao Y
J Cell Mol Med; 2020 Sep; 24(18):10279-10289. PubMed ID: 32745356
[TBL] [Abstract][Full Text] [Related]
4. MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy.
Gautam SK; Kumar S; Dam V; Ghersi D; Jain M; Batra SK
Semin Immunol; 2020 Feb; 47():101391. PubMed ID: 31952903
[TBL] [Abstract][Full Text] [Related]
5. MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma.
Gautam SK; Kumar S; Cannon A; Hall B; Bhatia R; Nasser MW; Mahapatra S; Batra SK; Jain M
Expert Opin Ther Targets; 2017 Jul; 21(7):657-669. PubMed ID: 28460571
[TBL] [Abstract][Full Text] [Related]
6. Do novel treatment strategies enhance T cell-mediated Immunity: Opportunities and challenges in pancreatic cancer immunotherapy.
Luo W; Zheng L; Zhang T
Int Immunopharmacol; 2021 Jan; 90():107199. PubMed ID: 33246828
[TBL] [Abstract][Full Text] [Related]
7. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
[TBL] [Abstract][Full Text] [Related]
8. Significance of mucin expression in pancreatobiliary neoplasms.
Yonezawa S; Higashi M; Yamada N; Yokoyama S; Goto M
J Hepatobiliary Pancreat Sci; 2010 Mar; 17(2):108-24. PubMed ID: 19787286
[TBL] [Abstract][Full Text] [Related]
9. NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer.
Kumar S; Das S; Rachagani S; Kaur S; Joshi S; Johansson SL; Ponnusamy MP; Jain M; Batra SK
Oncogene; 2015 Sep; 34(37):4879-89. PubMed ID: 25531332
[TBL] [Abstract][Full Text] [Related]
10. Immunoprevention of Pancreatic Cancer.
Rao CV; Mohammed A; Asch AS; Janakiram NB
Curr Med Chem; 2018; 25(22):2576-2584. PubMed ID: 28240168
[TBL] [Abstract][Full Text] [Related]
11. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.
Andrianifahanana M; Moniaux N; Schmied BM; Ringel J; Friess H; Hollingsworth MA; Büchler MW; Aubert JP; Batra SK
Clin Cancer Res; 2001 Dec; 7(12):4033-40. PubMed ID: 11751498
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapies for pancreatic cancer.
Ma Q
Curr Pharm Des; 2012; 18(17):2393-4. PubMed ID: 22372496
[No Abstract] [Full Text] [Related]
13. Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines.
Balagué C; Gambús G; Carrato C; Porchet N; Aubert JP; Kim YS; Real FX
Gastroenterology; 1994 Apr; 106(4):1054-61. PubMed ID: 8143972
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
Amedei A; Niccolai E; Prisco D
Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
[TBL] [Abstract][Full Text] [Related]
15. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of a human pancreatic adenocarcinoma mucin.
Khorrami AM; Choudhury A; Andrianifahanana M; Varshney GC; Bhattacharyya SN; Hollingsworth MA; Kaufman B; Batra SK
J Biochem; 2002 Jan; 131(1):21-9. PubMed ID: 11754731
[TBL] [Abstract][Full Text] [Related]
17. Mucins and mucin binding proteins in colorectal cancer.
Byrd JC; Bresalier RS
Cancer Metastasis Rev; 2004; 23(1-2):77-99. PubMed ID: 15000151
[TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical study of mucins in chronic pancreatitis and ductal adenocarcinoma of the pancreas].
Paklina OV; Setdikova GR
Arkh Patol; 2008; 70(4):13-7. PubMed ID: 18807519
[TBL] [Abstract][Full Text] [Related]
19. Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy.
Moniaux N; Andrianifahanana M; Brand RE; Batra SK
Br J Cancer; 2004 Nov; 91(9):1633-8. PubMed ID: 15494719
[TBL] [Abstract][Full Text] [Related]
20. Serological pancreatic tumor markers and the MUC1 apomucin.
Ho JJ; Kim YS
Pancreas; 1994 Nov; 9(6):674-91. PubMed ID: 7846010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
